Literature DB >> 35156836

Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.

Greater Kayode Oyejobi1,2,3,4, Dongyan Xiong1,2, Mengjuan Shi1,2, Xiaoxu Zhang1,2, Hang Yang1, Heng Xue1,2, Faith Ogolla1,2,5,4, Hongping Wei1,5.   

Abstract

With the increasing morbidity and mortality rates associated with multidrug-resistant bacteria, interest in bacteriophage therapy has been revived. However, bacterial resistance to phage infection threatens the usefulness of phage therapy, especially its inclusion in modern medicine. Multidrug-resistant Acinetobacter baumannii is a top-priority pathogen requiring urgent intervention and new therapeutic approaches, such as phage therapy. Here, we experimentally adapted A. baumannii WHG40004 to its lytic phage P21 and thereafter isolated a phage-resistant bacterial mutant, named Ev5-WHG. We then aimed to identify potential agents to aid phage killing of Ev5-WHG by analyzing its genome and that of the wild-type strain. The enriched Gene Ontology (GO) analysis based on genetic alterations in minor alleles and mutations showed that pathways such as zinc ion transport and cell membrane synthesis could play certain roles in phage resistance. Remarkably, the combination of zinc acetate and P21 showed increased bactericidal effect on Ev5-WHG. Significantly also, we showed that P21 completely prevented the growth of wild-type WHG40004 in the presence of antibiotics (meropenem and imipenem). The results from this study indicate that the analysis of phage resistance signatures during adaptation of bacteria to a lytic phage can inform the choice of agents to work cooperatively with phage to limit and/or reverse resistance. This approach could be important for guiding future successful phage therapy. IMPORTANCE Bacteriophages have proven very useful as alternative therapeutic agents in combating multidrug-resistant bacterial infections; however, bacterial resistance to phages threatens their use. In this study, we showed a new strategy of leveraging genetic signatures that accompany phage resistance in bacteria to predict agents that can be used with lytic phages to combat multidrug-resistant Acinetobacter baumannii. Significantly, this approach was helpful in suggesting the use of zinc acetate to reduce resistance in phage-resistant bacteria, as well as the use of phage with antibiotics meropenem and imipenem to prevent resistance in a wild-type strain of multidrug-resistant A. baumannii. The approach of this study will be helpful for improving the outcome of phage therapy and in overcoming antimicrobial resistance.

Entities:  

Keywords:  Acinetobacter baumannii; antimicrobial resistance; genetic polymorphism; microbial adaptation; phage resistance; phage therapy

Mesh:

Substances:

Year:  2022        PMID: 35156836      PMCID: PMC8923232          DOI: 10.1128/jb.00593-21

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.476


  50 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Selection and Characterization of Phage-Resistant Mutant Strains of Listeria monocytogenes Reveal Host Genes Linked to Phage Adsorption.

Authors:  Thomas Denes; Henk C den Bakker; Jeffrey I Tokman; Claudia Guldimann; Martin Wiedmann
Journal:  Appl Environ Microbiol       Date:  2015-04-17       Impact factor: 4.792

3.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.

Authors:  Irith Wiegand; Kai Hilpert; Robert E W Hancock
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture.

Authors:  Katsunori Mizoguchi; Masatomo Morita; Curt R Fischer; Masatoshi Yoichi; Yasunori Tanji; Hajime Unno
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

5.  Mechanism of Anti-bacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Vishvanath Tiwari; Neha Mishra; Keval Gadani; P S Solanki; N A Shah; Monalisa Tiwari
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

6.  Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection.

Authors:  Stephanie LaVergne; Theron Hamilton; Biswajit Biswas; M Kumaraswamy; R T Schooley; Darcy Wooten
Journal:  Open Forum Infect Dis       Date:  2018-03-23       Impact factor: 3.835

7.  Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease.

Authors:  Xin Tan; Huaisheng Chen; Min Zhang; Ying Zhao; Yichun Jiang; Xueyan Liu; Wei Huang; Yingfei Ma
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 5.293

8.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Hubert Hackl; Pornpimol Charoentong; Marie Tosolini; Amos Kirilovsky; Wolf-Herman Fridman; Franck Pagès; Zlatko Trajanoski; Jérôme Galon
Journal:  Bioinformatics       Date:  2009-02-23       Impact factor: 6.937

9.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

10.  Adapting a Phage to Combat Phage Resistance.

Authors:  Elina Laanto; Kati Mäkelä; Ville Hoikkala; Janne J Ravantti; Lotta-Riina Sundberg
Journal:  Antibiotics (Basel)       Date:  2020-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.